Transoesophageal endoscopic ultrasound with bronchoscope: insights from an Australian Local Health District ahead of lung cancer screening
Internal Medicine Journal · 2025
DOI: 10.1111/imj.70113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Matthew Lindfield und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Sleep Medicine, The Canberra Hospital, Canberra, Australian Capital Territory, Australia. Hauptthemen laut MEDLINE: Lung Neoplasms, Endoscopic Ultrasound-Guided Fine Needle Aspiration, Early Detection of Cancer, Bronchoscopy. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The combined use of endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) and transoesophageal endoscopic ultrasound with bronchoscope‐guided fine‐needle aspiration (EUS‐B‐FNA) is preferred in the diagnosis and staging of non‐small cell lung cancer (NSCLC); however, there is limited utilisation of EUS‐B‐FNA in Australia. With a National Lung Cancer Screening program (NLCSP) commencing in 2025, additional diagnostics may be required by bronchoscopists.
Aims
We describe the endoscopic model of care offered and outcomes achieved by Respiratory Physicians experienced in EUS‐B‐FNA practicing in a regional Australian tertiary referral hospital.
Methods
Adult patients within the Hunter New England Local Health District (HNELDH) who underwent a diagnostic/staging EBUS‐TBNA or EUS‐B‐FNA procedures, as recorded in a prospectively collected procedural database from 2016 to 2022, were included.
Results
1564 patients (688 female), median age 68 years had a diagnostic or staging EBUS‐TBNA and/or EUS‐B‐FNA (1268 EBUS‐TBNA, 262 EUS‐B‐FNA and 34 combined). The diagnostic yield for procedures performed with an indication of suspected lung malignancy was as follows: EBUS‐TBNA: 75.5%, EUS‐B‐FNA: 85.7%, and combined procedure: 61.1%. Three major infectious complications were observed in EUS‐B‐FNA (1.15%) and two in EBUS‐TBNA (0.16%). These complications precede the institution's policy of pre‐procedural antibiotic prophylaxis started in 2021.
Conclusion
EUS‐B‐FNA can be performed safely by competent EBUS‐TBNA respiratory physicians provided that prospective data and complication monitoring are in place.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Sleep Medicine, The Canberra Hospital, Canberra, Australian Capital Territory, Australia.
- The Australian National University, Canberra, Australian Capital Territory, Australia.
- Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia.
- The University of Newcastle, Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
ORCID-Profile: Matthew Lindfield
Zitieren
APA
Lindfield, M., Lloyd, A., George, V., Grainge, C., Twaddell, S., & Arnold, D. (2025). Transoesophageal endoscopic ultrasound with bronchoscope: insights from an Australian Local Health District ahead of lung cancer screening. Internal Medicine Journal. https://doi.org/10.1111/imj.70113
Vancouver
Lindfield M, Lloyd A, George V, Grainge C, Twaddell S, Arnold D. Transoesophageal endoscopic ultrasound with bronchoscope: insights from an Australian Local Health District ahead of lung cancer screening. Internal Medicine Journal. 2025. doi:10.1111/imj.70113
BibTeX
@article{Lindfield2025,
author = {Lindfield, Matthew and Lloyd, Angus and George, Vineeth and Grainge, Christopher and Twaddell, Scott and Arnold, David},
title = {Transoesophageal endoscopic ultrasound with bronchoscope: insights from an Australian Local Health District ahead of lung cancer screening},
journal = {Internal Medicine Journal},
year = {2025},
doi = {10.1111/imj.70113}
}
EUVIMED